News
![Janssen J&J Johnson and Johnson pharmaceutical companies](https://pharmaphorum.com/wp-content/uploads/2018/06/Janssen_JJ_Johnson_and_Johnson_pharmaceutical_companies.jpg)
J&J files lung cancer bispecific amivantamab for FDA approva...
Johnson & Johnson has filed its bispecific antibody amivantamab to the FDA, hoping to muscle into the big market for drugs that are used to treat EGFR-positive non-small cell lung cance